Nasus Pharma

NSRXNYSE Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$40.285 M

$3.44 -2.55%

Close of 21 Sept 2026

Revenue

$1.24B

#1405 by revenue

Earnings

-$5.86M

Loss-making

Shares outstanding

9,015,383

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#364Seres TherapeuticsMCRB$40.9M
#365Lite StrategyLITS$40.8M
#366Nasus PharmaNSRX$40.3M
#367Actinium PharmaceuticalsATNM$37.7M
#368Mira PharmaceuticalsMIRA$36.9M

What if Nasus Pharma were worth as much as…

Open the what-if tool →

Gold $30.3T

$2,585,138

Per share 751,494× higher

Bitcoin $1.72T

$146,856.11

Per share 42,691× higher

Nvidia $5.48T

$467,931.67

Per share 136,027× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Nasus Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.